You Don’t Want to MIS-C This: Case Studies Differentiating MIS-C from Other Inflammatory Syndromes

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Multisystem Inflammatory Syndrome in Children (MIS-C) has emerged as a new pediatric disease in the wake of the COVID-19 pandemic. In this session, advanced concepts including the proposed mechanism of MIS-C pathophysiology are presented. Case studies illustrate differences in laboratory and clinical findings of MIS-C compared with those of other pediatric inflammatory diseases. Therapeutic regimens for each are presented based on the current evidence.

Objectives

Define MIS-C and describe its pathophysiology, along with that of other inflammatory diseases.
Distinguish between clinical and laboratory findings of MIS-C and other inflammatory diseases such as Kawasaki disease.
Describe the management of MIS-C and other inflammatory disease such as Kawasaki disease.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.